Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-11
DOI
10.1186/s13045-020-00919-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement in Motion: The Evolution of CD46 from a Complement Regulator to an Orchestrator of Normal Cell Physiology
- (2019) M. Kathryn Liszewski et al. JOURNAL OF IMMUNOLOGY
- Oncolytic Measles Virotherapy and Opposition to Measles Vaccination
- (2019) Stephen J. Russell et al. MAYO CLINIC PROCEEDINGS
- Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
- (2018) Anne Slomp et al. Frontiers in Oncology
- Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma
- (2017) A Dispenzieri et al. LEUKEMIA
- Oncolytic Virotherapy: A Contest between Apples and Oranges
- (2017) Stephen J. Russell et al. MOLECULAR THERAPY
- Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
- (2017) Daniel E. Meyers et al. Frontiers in Oncology
- Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells
- (2016) Mee Y. Bartee et al. Clinical Lymphoma Myeloma & Leukemia
- Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
- (2016) Daniel W. Sherbenou et al. JOURNAL OF CLINICAL INVESTIGATION
- Measles to the Rescue: A Review of Oncolytic Measles Virus
- (2016) Sarah Aref et al. Viruses-Basel
- Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy
- (2015) J. J. Rojas et al. CLINICAL CANCER RESEARCH
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects
- (2014) J. Y. Yoo et al. CLINICAL CANCER RESEARCH
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy
- (2014) Stephen J. Russell et al. MAYO CLINIC PROCEEDINGS
- Reovirus modulates autophagy during oncolysis of multiple myeloma
- (2013) Chandini M. Thirukkumaran et al. Autophagy
- Reovirus as a successful ex vivo purging modality for multiple myeloma
- (2013) C M Thirukkumaran et al. BONE MARROW TRANSPLANTATION
- Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
- (2013) S. Eisenstein et al. CANCER RESEARCH
- Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo
- (2013) Danielle N. Yarde et al. EXPERIMENTAL HEMATOLOGY
- Oncolytic Virotherapy
- (2013) Daniel Y. Sze et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma
- (2012) C. M. Thirukkumaran et al. CLINICAL CANCER RESEARCH
- Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction and augments bortezomib-mediated apoptosis in multiple myeloma
- (2011) K R Kelly et al. ONCOGENE
- Multiple myeloma: biology of the disease
- (2010) Anuj Mahindra et al. BLOOD REVIEWS
- Novel therapeutic targets for multiple myeloma
- (2010) Anuj Mahindra et al. Future Oncology
- Dynamics of multiple myeloma tumor therapy with a recombinant measles virus
- (2009) D Dingli et al. CANCER GENE THERAPY
- Cellular Targeting of Engineered Heterologous Antigens Is a Determinant Factor for Bovine Herpesvirus 4-Based Vaccine Vector Development
- (2009) G. Donofrio et al. Clinical and Vaccine Immunology
- Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cells
- (2009) H.-D. Hummel et al. JOURNAL OF GENERAL VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More